Anthranilic Acid
Anthranilic acid is an organic compound identified as a key metabolite within the human body. Its presence and levels in biological fluids, such as serum, are subjects of metabolomics research, which aims to comprehensively measure endogenous metabolites to understand the physiological state of an individual. [1] Genetic variations can influence the homeostasis of various metabolites, including anthranilic acid, offering insights into human health and disease susceptibility. [1]
Background
Metabolomics, a rapidly expanding field, focuses on the systematic study of small-molecule metabolites within cells, tissues, or organisms. By analyzing metabolite profiles, researchers can gain a functional readout of the body's physiological condition. Genome-wide association studies (GWAS) have been employed to identify genetic variants associated with alterations in metabolite levels, including anthranilic acid, in human serum. [1] These studies contribute to a deeper understanding of how an individual's genetic makeup influences their metabolic landscape.
Biological Basis
Anthranilic acid is an important intermediate in various metabolic pathways, particularly in the biosynthesis and degradation of tryptophan, an essential amino acid. As a metabolite, it participates in the intricate network of biochemical reactions that maintain cellular function and overall physiological balance. Genetic variants can affect the enzymes or transporters involved in these pathways, thereby influencing the production, utilization, or excretion of metabolites like anthranilic acid. Understanding these genetic influences is crucial for elucidating the underlying biological mechanisms that govern metabolite levels. [1]
Clinical Relevance
Variations in metabolite levels, including those of anthranilic acid, can serve as biomarkers for physiological states and may be linked to the risk of various diseases. Research suggests that genetic variants associated with changes in metabolite homeostasis could be relevant to complex traits and diseases. [1] While specific clinical implications for anthranilic acid levels are still being explored, the broader field of metabolomics links metabolite profiles to conditions such as coronary artery disease, Crohn's disease, hypertension, rheumatoid arthritis, and type 1 and type 2 diabetes mellitus. [1] Therefore, genetic factors influencing anthranilic acid levels may play a role in the predisposition or progression of such health conditions.
Social Importance
The study of metabolites and their genetic determinants holds significant social importance through its potential impact on personalized medicine and public health. By identifying genetic variants that influence metabolite levels, researchers can develop more precise diagnostic tools, predict disease risk, and tailor preventative strategies or therapeutic interventions to an individual's unique genetic and metabolic profile. This knowledge contributes to a more nuanced understanding of human health, moving towards a future where medical treatments are increasingly personalized and effective.
Methodological and Statistical Constraints
The interpretability and generalizability of findings from genome-wide association studies are often constrained by inherent methodological and statistical limitations. Many studies, particularly those with moderate sample sizes, may possess insufficient statistical power to reliably detect genetic variants with modest effect sizes, potentially leading to false-negative results or an overestimation of effects for initially identified associations. [2] Furthermore, the reliance on asymptotic assumptions for calculating p-values means that extremely low p-values might not be precisely accurate, requiring careful interpretation as indicators rather than definitive measures of association. [1] The extensive multiple testing inherent in GWAS necessitates stringent significance thresholds (e.g., Bonferroni correction), which, while reducing false positives, can further diminish power to detect true associations.
Challenges also arise from the imputation of untyped single nucleotide polymorphisms (SNPs), where the accuracy of imputed genotypes is critical. While studies often employ high confidence thresholds for imputed SNPs (e.g., R-square > 0.3 or posterior probability > 0.90) and report error rates, these estimations of missing genotypes introduce a degree of uncertainty. [3] Moreover, the lack of consistent replication across studies, with some meta-analyses showing replication for only about one-third of associations, highlights the potential for false positive findings, cohort-specific effects, or insufficient power in replication cohorts. [2] Non-replication at the SNP level can also occur if different SNPs within the same gene are in strong linkage disequilibrium with an unobserved causal variant, or if multiple causal variants exist within a gene.
Generalizability and Population Specificity
The demographic characteristics of study cohorts significantly impact the generalizability of genetic findings. Many large-scale GWAS cohorts are predominantly composed of individuals of European descent and often span middle-aged to elderly populations. [2] This demographic skew means that findings may not be directly transferable or generalizable to younger individuals or populations of different ethnic or racial backgrounds, where allele frequencies, linkage disequilibrium patterns, and environmental exposures can vary substantially. [2] Consequently, the observed genetic associations might be specific to the studied population and require validation in diverse populations to confirm their broader relevance.
Population stratification, even within seemingly homogeneous groups, poses a risk for spurious associations if not adequately addressed. Although studies commonly employ methods such as genomic control or principal component analysis to account for population substructure, residual effects can persist and influence results, particularly in genetically isolated or founder populations. [4] Additionally, the timing of biological sample collection, such as DNA extraction at later examination cycles in longitudinal studies, can introduce a survival bias, potentially limiting the representativeness of the cohort to the broader population and affecting the interpretation of associations. [2]
Phenotypic Nuance and Environmental Interplay
The precise and consistent measurement of phenotypes is crucial for robust genetic association studies, yet variability can introduce considerable noise. Differences in demographic composition between populations and methodological variations in assays can lead to disparities in mean phenotype levels, complicating direct comparisons and meta-analyses across studies. [5] While some studies average multiple observations per individual or utilize data from monozygotic twins to enhance phenotype reliability, the specific methods for handling phenotypic variance can still influence the estimated effect sizes and the proportion of variance explained by genetic variants. [4] The use of derived measures, such as metabolite ratios, can reduce overall variance and improve statistical power, but also adds a layer of complexity to the direct interpretation of genetic effects on individual raw measurements. [1]
A significant limitation in understanding complex traits is the incomplete exploration of gene-environment interactions. Genetic variants often influence phenotypes in a context-specific manner, with their effects modulated by various environmental factors. [6] For instance, associations between genes like ACE and AGTR2 with left ventricular mass have been shown to vary with dietary salt intake, highlighting the importance of considering such interactions. [6] Many studies, however, do not systematically investigate these complex gene-environmental interactions, which can lead to an underestimation of the total genetic influence and leave substantial gaps in understanding the full etiology of complex traits. [3] This lack of comprehensive assessment contributes to the "missing heritability" phenomenon, where identified genetic variants explain only a fraction of the observed phenotypic variance.
Variants
Genetic variants play a crucial role in shaping individual biological traits and disease susceptibility by influencing gene expression and protein function. The long intergenic non-coding RNAs LINC01153 and LINC01692, along with the histone deacetylase HDAC4, represent key regulators of these processes. LINC01153 and LINC01692 are non-coding RNA molecules that can modulate gene expression through various mechanisms, such as chromatin remodeling or transcriptional interference, thereby affecting cellular pathways. [7] A variant like rs17101702 in LINC01153 or rs2829495 in LINC01692 could alter the regulatory capacity of these lncRNAs, potentially leading to widespread changes in gene activity. Similarly, HDAC4 (Histone Deacetylase 4) is a crucial enzyme that removes acetyl groups from histones, thereby compacting chromatin and repressing gene transcription. [2] The rs4852019 variant in HDAC4 could impact its enzymatic activity or cellular localization, leading to altered expression of numerous genes involved in cell differentiation, metabolism, and neuronal function. Such broad transcriptional changes, whether from lncRNA or HDAC4 variations, could influence the intricate metabolic pathways involving anthranilic acid, a tryptophan metabolite known for its immunomodulatory and neuroactive properties, by altering the cellular environment or the expression of enzymes involved in its synthesis or degradation.
Variations in genes encoding ion channels and cellular transport proteins can profoundly affect cell signaling and physiological functions. The KCNQ1 gene encodes a voltage-gated potassium channel subunit crucial for cell excitability in tissues like the heart and pancreas, with KCNQ1OT1 regulating its expression through genomic imprinting. [5] The rs7130232 variant in this locus could impact ion channel function or its regulation, affecting cardiac rhythm or glucose homeostasis. Similarly, KIF1B and MYO3B are motor proteins essential for intracellular transport: KIF1B moves vesicles and mitochondria in neurons, and MYO3B contributes to inner ear stereocilia maintenance. A variant like rs17402390 in KIF1B or rs13035033 in MYO3B could impair these transport mechanisms, disrupting cellular organization. Furthermore, LNX1 (Ligand of Numb Protein X 1) is an E3 ubiquitin ligase that regulates protein degradation and cell signaling, with the rs6848923 variant potentially altering protein turnover. [7] These disruptions in fundamental cellular dynamics could influence the physiological context for anthranilic acid, a tryptophan metabolite with immunomodulatory and neuroactive properties, affecting its synthesis, metabolism, or biological impact.
The integrity of cellular processes, from DNA maintenance to protein modification, is vital for overall health. NSMCE2 (Non-SMC Element 2) is a subunit of the SMC5/SMC6 complex, which plays a critical role in DNA repair and maintaining genome stability, particularly during DNA replication and in response to DNA damage. [2] A variant such as rs4871580 in NSMCE2 could compromise these DNA repair mechanisms, increasing cellular susceptibility to damage and potentially impacting cell survival or proliferation. Concurrently, COG5 (Component of Oligomeric Golgi Complex 5) is an essential subunit of the conserved oligomeric Golgi complex, which is indispensable for the proper structure and function of the Golgi apparatus, a cellular organelle critical for protein glycosylation, sorting, and transport. [5] Variants like rs1859294 and rs2023685 in COG5 could lead to impaired glycosylation, affecting a wide array of proteins involved in cell-cell communication, immune response, and metabolism. Disruptions in either genomic integrity via NSMCE2 or protein processing via COG5 could significantly alter cellular homeostasis, thereby modulating the body's response to or metabolism of anthranilic acid, a bioactive tryptophan derivative with recognized roles in inflammation and neurological pathways.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs17101702 | LINC01153 - RN7SKP167 | anthranilic acid measurement |
| rs7130232 | KCNQ1OT1, KCNQ1 | anthranilic acid measurement |
| rs17402390 | KIF1B | anthranilic acid measurement |
| rs13035033 | MYO3B | anthranilic acid measurement BMI-adjusted hip circumference |
| rs4852019 | HDAC4 | anthranilic acid measurement |
| rs2829495 | LINC01692 | anthranilic acid measurement |
| rs4871580 | NSMCE2 | anthranilic acid measurement |
| rs6848923 | LNX1 - RPL21P44 | anthranilic acid measurement |
| rs1859294 | COG5 | anthranilic acid measurement aspartate measurement glutamate measurement carnosine measurement |
| rs2023685 | COG5 | anthranilic acid measurement |
Metabolic Regulation and Lipid Homeostasis
The regulation of lipid metabolism involves several intricate pathways, exemplified by the mevalonate pathway where HMGCR plays a crucial role in cholesterol biosynthesis. [8] Genetic variations, such as common single nucleotide polymorphisms (SNPs) in HMGCR, can impact alternative splicing of exon13, thereby affecting HMGCR activity and ultimately influencing LDL-cholesterol levels. [9] Furthermore, the degradation rate of HMGCR can be influenced by its oligomerization state, highlighting a complex regulatory layer that determines the availability of this key enzyme. [10] Beyond cholesterol, fatty acid metabolism is also subject to genetic influence, with variations impacting metabolic outcomes and conditions like medium-chain acyl-CoA dehydrogenase deficiency (ACADM). [11]
Another critical aspect of metabolic regulation concerns uric acid homeostasis, primarily mediated by specific transporters. The GLUT9 (SLC2A9) gene is significantly associated with serum uric acid levels, functioning as a renal urate anion exchanger that precisely controls blood urate concentrations. [12] Complementing this, the SLC22A12 gene also encodes a renal urate anion exchanger, contributing to the overall regulation of urate transport and maintaining metabolic balance. [13] The Adiponutrin gene, involved in lipid metabolism, demonstrates metabolic regulation as its expression is influenced by both insulin and glucose in human adipose tissue, with genetic variations in this gene linked to obesity. [14]
Genetic and Post-Translational Regulatory Mechanisms
Gene expression and protein function are extensively controlled through various regulatory mechanisms, including alternative splicing and post-translational modifications. Alternative splicing is a fundamental process that generates diverse protein isoforms from a single gene, with common SNPs capable of altering splicing patterns, as seen with HMGCR and its impact on LDL-cholesterol. [9] This mechanism is vital for biological complexity and is frequently implicated in human diseases. [15] The APOB mRNA, for instance, can undergo antisense oligonucleotide-induced alternative splicing to produce novel isoforms, showcasing the precise control over protein output. [16]
Beyond splicing, protein function is finely tuned by post-translational modifications. An example is the phosphorylation of Heat Shock Protein-90 (HSP90) by Thyroid Stimulating Hormone (TSH) in thyroid cells. [17] This modification can alter HSP90's activity or interactions, thereby modulating its role in protein folding and cellular stress responses. These regulatory layers, from transcriptional control to dynamic protein modifications, underscore the sophisticated mechanisms governing cellular processes and maintaining physiological integrity.
Cellular Signaling and Receptor Activation
Cellular functions are orchestrated by intricate signaling pathways involving receptor activation and downstream cascades. The Mitogen-Activated Protein Kinase (MAPK) pathway represents a widely recognized intracellular signaling cascade, which can be activated in response to various stimuli, including age and acute exercise, influencing cellular responses in human skeletal muscle. [6] This pathway typically involves a series of phosphorylations that transmit signals from the cell surface to the nucleus, regulating gene expression and cellular activities.
Another significant signaling axis involves cGMP regulation, where phosphodiesterases play a critical role in modulating cyclic nucleotide levels. Angiotensin II, a potent vasoconstrictor, can increase the expression of phosphodiesterase 5A (PDE5A) in vascular smooth muscle cells, thereby antagonizing cGMP signaling and influencing vascular tone. [18] The PDE5 enzyme itself is central to the regulation of cGMP, impacting various physiological processes including vascular function. [19] Furthermore, the CFTR chloride channel, expressed in human endothelia and smooth muscle cells, mediates cAMP-dependent Cl-transport, and its disruption can alter mechanical properties and ion flow, highlighting its role in cellular signaling and function. [20]
Systems-Level Pathway Integration and Crosstalk
Biological systems are characterized by extensive pathway crosstalk and network interactions, where individual pathways do not operate in isolation but are hierarchically regulated to achieve emergent properties. Metabolomics, by comprehensively measuring endogenous metabolites, provides a functional readout of the physiological state, revealing how genetic variants can impact the homeostasis of key lipids, carbohydrates, or amino acids, thus delineating affected pathways and their interconnections. [1] This holistic view helps to understand different metabolic phenotypes in humans, indicating a complex interplay of genetic and environmental factors. [21]
Crosstalk between different physiological systems is also evident in cardiovascular regulation. For instance, the parallel gene expression of IL-6 and BNP during cardiac hypertrophy suggests an integrated inflammatory and cardiac stress response. [22] Moreover, the neuronal chemorepellent Slit2 has been shown to inhibit vascular smooth muscle cell migration by suppressing Rac1 activation, demonstrating a direct interaction between neuronal guidance cues and vascular remodeling processes. [23] These examples underscore how seemingly distinct pathways converge and interact to regulate complex biological outcomes.
Disease-Relevant Mechanisms and Therapeutic Implications
Dysregulation of specific pathways often underlies various diseases, presenting opportunities for therapeutic intervention. Dyslipidemia, characterized by abnormal lipid levels, is influenced by genetic variants in genes such as HMGCR that affect LDL-cholesterol, contributing to conditions like subclinical atherosclerosis. [9] The polygenic nature of dyslipidemia, involving common variants at multiple loci, further emphasizes the complexity of its underlying mechanisms. [7]
Similarly, hyperuricemia, or elevated serum uric acid, is linked to the dysregulation of urate transporters like GLUT9 (SLC2A9) and SLC22A12, which can lead to metabolic syndrome and renal disease. [12] Understanding these transport mechanisms provides potential targets for managing uric acid levels. In cardiac pathology, mutations in the cardiac ryanodine receptor gene (hRyR2) are known to cause catecholaminergic polyventricular tachycardia, highlighting channelopathies as a critical mechanism of cardiac dysfunction. [24] Such insights into disease-relevant mechanisms are crucial for developing targeted diagnostic and therapeutic strategies.
References
[1] Gieger, C. et al. "Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum." PLoS Genet, 2008.
[2] Benjamin, Emelia J., et al. "Genome-wide association with select biomarker traits in the Framingham Heart Study." BMC Medical Genetics, vol. 8, 2007.
[3] Dehghan, Abbas, et al. "Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study." Lancet, vol. 372, no. 9654, 2008, pp. 1823-1831.
[4] Benyamin, Beben, et al. "Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels." American Journal of Human Genetics, vol. 84, no. 1, 2009, pp. 60-65.
[5] Yuan, Xin, et al. "Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes." American Journal of Human Genetics, vol. 83, no. 5, 2008, pp. 520-528.
[6] Vasan, R.S. et al. "Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study." BMC Med Genet, 2007.
[7] Kathiresan, S. et al. "Common variants at 30 loci contribute to polygenic dyslipidemia." Nat Genet, 2006.
[8] Goldstein, J.L. and Brown, M.S. "Regulation of the mevalonate pathway." Nature, 1990.
[9] Burkhardt, R. et al. "Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13." Arterioscler Thromb Vasc Biol, 2009.
[10] Istvan, E.S. et al. "Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis." Embo J, 2000.
[11] Caspi, A. et al. "Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism." Proc Natl Acad Sci U S A, 2007.
[12] Li, S. et al. "The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts." PLoS Genet, 2007.
[13] Enomoto, A. et al. "Molecular identification of a renal urate anion exchanger that regulates blood urate levels." Nature, 2002.
[14] Moldes, M. et al. "Adiponutrin gene is regulated by insulin and glucose in human adipose tissue." Eur J Endocrinol, 2006.
[15] Matlin, A.J. et al. "Understanding alternative splicing: towards a cellular code." Nat Rev Mol Cell Biol, 2005.
[16] Khoo, B. et al. "Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB." BMC Mol Biol, 2007.
[17] Ginsberg, J. et al. "Phosphorylation of Heat Shock Protein-90 by TSH in FRTL-5 Thyroid Cells." Thyroid, 2006.
[18] Kim, D. et al. "Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling." J Mol Cell Cardiol, 2005.
[19] Lin, C.S. et al. "Expression, distribution and regulation of phosphodiesterase 5." Curr Pharm Des, 2006.
[20] Robert, R. et al. "Disruption of CFTR chloride channel alters mechanical properties and cAMP-dependent Cl-transport of mouse aortic smooth muscle cells." J Physiol (Lond), 2005.
[21] Assfalg, M. et al. "Evidence of different metabolic phenotypes in humans." Proc Natl Acad Sci U S A, 2008.
[22] Haugen, E. et al. "Parallel gene expressions of IL-6 and BNP during cardiac hypertrophy complicated with diastolic dysfunction in spontaneously hypertensive rats." Int J Cardiol, 2006.
[23] Liu, D. et al. "Neuronal chemorepellent Slit2 inhibits vascular smooth muscle cell migration by suppressing small GTPase Rac1 activation." Circ Res, 2006.
[24] Benkusky, N.A. et al. "Ryanodine receptor channelopathies." Biochem Biophys Res Commun, 2004.